tirzepatide court ruling FDA's decision creates uncertainty for patients—and leads to a lawsuit GLP-1 Drugs: FDA “Re-Confirms” Decision

When calculating volumes for a specific retatrutide dose, researchers should account for the concentration of the reconstituted solution

Food noise returns 36 weeks after the last dose as gastric emptying normalizes and GLP-1 receptor activation fades

A large meta-analysis by Sagoe et al., encompassing 271 studies, estimated the average lifetime prevalence of androgen use to be 6.4% among men and 1.6% among women

Cryptococcus: from environmental saprophyte to global pathogen

The change in body weight, fat mass, and lean mass from baseline to week 72 was 21.3 percent, 33.9 percent, and 10.9 percent respectively with tirzepatide